Related Experiment Videos
[What can be expected from off-pump coronary artery surgery?]
1Service d'anesthésie-réanimation et équipe d'accueil 1896, hôpital cardiovasculaire et pneumologique Louis-Pradel, BP Lyon-Montchat, 69394 Lyon cedex 03, France. jean-jacques.lehot@chu-lyon.fr
Annales Francaises D'Anesthesie Et De Reanimation
|December 8, 2004
Summary
Off-pump coronary artery bypass surgery may reduce injury markers and costs compared to on-pump surgery. However, benefits are not seen in low-risk patients, and incomplete revascularization is a concern.
Area of Science:
- Cardiovascular Surgery
- Cardiac Anesthesia
- Clinical Trials
Context:
- Off-pump coronary artery bypass (OPCAB) surgery has gained prominence.
- Seven randomized studies with over 60 patients compare OPCAB to on-pump coronary artery bypass (CABG).
- Focus on anesthesia, monitoring, and hemodynamic complications.
Purpose:
- To compare outcomes of off-pump versus on-pump coronary artery bypass surgery.
- To analyze biochemical markers, complications, and resource utilization.
Summary:
- Randomized studies indicate OPCAB leads to less myocardial and renal injury, reduced fluid retention, fewer cerebral microemboli, and decreased need for blood transfusions.
- OPCAB also shows shorter hospital stays and lower overall costs.
- No significant differences in myocardial infarction, atrial fibrillation, stroke, renal failure, reoperation, infection, or mortality were found in low-risk patients.
Impact:
- Non-randomized studies suggest potential benefits in stroke and mortality for elderly patients undergoing OPCAB.
- The risk of incomplete revascularization remains a critical consideration for OPCAB.
- Evidence supports OPCAB in specific patient groups, highlighting the need for careful patient selection.